Ho Seok Seo1, Han Hong Lee2. 1. Division of Gastrointestinal Surgery, Department of Surgery, College of Medicine, The Catholic University of Korea, Seoul, South Korea. 2. Division of Gastrointestinal Surgery, Department of Surgery, College of Medicine, The Catholic University of Korea, Seoul, South Korea. Electronic address: painkiller9@catholic.ac.kr.
Abstract
BACKGROUND/AIM: Interest of gastric cancer patients in the quality of life postoperatively with respect to reduced scarring is increasing. This study aimed to evaluate the feasibility of reduced-port totally laparoscopic gastrectomy (RepTLG) for the treatment of gastric cancer. METHODS: In total, 170 patients who underwent RepTLG (n = 97) or conventional totally laparoscopic gastrectomy (cTLG) (n = 73) were enrolled. Clinicopathological features, operative details, and short-term postoperative outcomes were analyzed retrospectively and compared between groups. RESULTS: There were no significant differences for preoperative comorbidity between the RepTLG and c TLG groups, although patients in the RepTLG group were older than those in the cTLG group (63.5 ± 11.1 vs. 59.3 ± 10.6; p = 0.014). Operating time was shorter in the RepTLG group compared to the cTLG group (187.5 ± 67.7 min vs. 219.6 ± 43.3 min; p < 0.001) and duration of flatus of the RepTLG group was shorter than that of the cTLG group (2.7 ± 0.6 days vs. 2.9 ± 0.8 days; p = 0.016). CONCLUSION: RepTLG is a reliable scar reducing method with good operative and short-term outcomes for the treatment of gastric cancer compared with cTLG.
BACKGROUND/AIM: Interest of gastric cancerpatients in the quality of life postoperatively with respect to reduced scarring is increasing. This study aimed to evaluate the feasibility of reduced-port totally laparoscopic gastrectomy (RepTLG) for the treatment of gastric cancer. METHODS: In total, 170 patients who underwent RepTLG (n = 97) or conventional totally laparoscopic gastrectomy (cTLG) (n = 73) were enrolled. Clinicopathological features, operative details, and short-term postoperative outcomes were analyzed retrospectively and compared between groups. RESULTS: There were no significant differences for preoperative comorbidity between the RepTLG and c TLG groups, although patients in the RepTLG group were older than those in the cTLG group (63.5 ± 11.1 vs. 59.3 ± 10.6; p = 0.014). Operating time was shorter in the RepTLG group compared to the cTLG group (187.5 ± 67.7 min vs. 219.6 ± 43.3 min; p < 0.001) and duration of flatus of the RepTLG group was shorter than that of the cTLG group (2.7 ± 0.6 days vs. 2.9 ± 0.8 days; p = 0.016). CONCLUSION: RepTLG is a reliable scar reducing method with good operative and short-term outcomes for the treatment of gastric cancer compared with cTLG.